PCSK9 in African Americans and Caucasians in Relation to Lp(a) Level, Apo(a) Size and Heritability

CONTEXT: Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces lipoprotein(a) [Lp(a)] levels, but the association of PCSK9 with Lp(a) level and its major determinant, apolipoprotein(a) [apo(a)] size, is not fully understood. OBJECTIVE: To assess the relationship between PCSK9,...

Descripción completa

Detalles Bibliográficos
Autores principales: Enkhmaa, Byambaa, Kim, Kyoungmi, Zhang, Wei, Prakash, Nishant, Truax, Kevin, Anuurad, Erdembileg, Berglund, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358566/
https://www.ncbi.nlm.nih.gov/pubmed/32685870
http://dx.doi.org/10.1210/jendso/bvaa073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358566/
https://www.ncbi.nlm.nih.gov/pubmed/32685870
http://dx.doi.org/10.1210/jendso/bvaa073

Ejemplares similares